Cancer risk in patients treated with denosumab compared with alendronate: A population-based cohort study.
Yahyavi SK, Holt R, Knudsen NK, Andreassen CH, Sejling C, Meddis A, Kjaer SK, Schwarz P, Jensen JB, Torp-Pedersen C, Juul A, Selmer C, Blomberg Jensen M.
Yahyavi SK, et al. Among authors: holt r.
Bone. 2024 May;182:117053. doi: 10.1016/j.bone.2024.117053. Epub 2024 Feb 21.
Bone. 2024.
PMID: 38395247